Matthew Kent Selected Research

Matthew Kent Research Topics

9	Neoplasms (Cancer) 01/2022 - 03/2013
4	Carcinoma (Carcinomatosis) 10/2020 - 03/2013
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2023 - 10/2020
2	Melanoma (Melanoma, Malignant) 03/2022 - 10/2020
2	Prostatic Neoplasms (Prostate Cancer) 08/2013 - 02/2013
2	Mastitis 08/2011 - 11/2009
1	Neoplasm Metastasis (Metastasis) 03/2022
1	Hypothermia 01/2020
1	Non-Muscle Invasive Bladder Neoplasms 01/2018
1	Kidney Neoplasms (Kidney Cancer) 07/2016
1	Chronic Renal Insufficiency 06/2015
1	Renal Cell Carcinoma (Grawitz Tumor) 09/2014
1	Lymphadenopathy 09/2014
1	Necrosis 06/2014
1	Hernia (Hernias) 06/2014
1	Urinary Bladder Neoplasms (Bladder Cancer) 04/2014
1	Hemophilia A (Haemophilia) 07/2012

2	AlbuminsIBA 06/2014 - 06/2014
2	Proteins (Proteins, Gene)FDA Link 08/2011 - 11/2009
1	Dexamethasone (Maxidex)FDA LinkGeneric 03/2022
1	Tyrosine Kinase InhibitorsIBA 01/2022
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	Adrenal Cortex Hormones (Corticosteroids)IBA 10/2020
1	Immune Checkpoint InhibitorsIBA 10/2020
1	cyclopropapyrroloindoleIBA 10/2020
1	Mitomycin (Mitomycin-C)FDA LinkGeneric 01/2018
1	P 11 (P-11)IBA 06/2015
1	Biological FactorsIBA 06/2014
1	CI 22IBA 06/2014
1	Cisplatin (Platino)FDA LinkGeneric 04/2014
1	Milk Proteins (Milk Protein)IBA 08/2011

4	Cystectomy 08/2015 - 03/2013
3	Therapeutics 03/2022 - 10/2020
3	Drug Therapy (Chemotherapy) 03/2022 - 04/2014
3	Nephrectomy 07/2016 - 09/2014
3	Prostatectomy (Retropubic Prostatectomy) 07/2014 - 02/2013
2	Immunotherapy 03/2022 - 01/2022
2	Lymph Node Excision (Lymph Node Dissection) 12/2014 - 09/2014
1	Adjuvant Chemotherapy 01/2023
1	Operative Surgical Procedures 01/2020
1	Intravesical Administration 01/2018
1	Nephroureterectomy 06/2014
1	Neoadjuvant Therapy 04/2014
1	Salvage Therapy 08/2013
1	Radiotherapy 08/2013
1	Conservative Treatment 07/2012